From: ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?
Total | Platelet count × 109/l | Bleeding score adapted to Buchanan et al. | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N (%) | 0–9 | 10–19 | 20–29 | > 30 | 0 (None) | 1 (Minor) | 2 (Mild) | 3 (Moderate) | 4 (Severe) | 5 (Life threatening) | |
No therapy | 95 (44%) | 49 | 19 | 16 | 11 | 4 | 31 | 36 | 23 | 1 | 0 |
IVIG | 59 (27%) | 51 | 4 | 3 | 1 | 3 | 13 | 18 | 24 | 1 | 0 |
GC | 33 (15%) | 22 | 9 | 1 | 1 | 1 | 4 | 8 | 19 | 1 | 0 |
IVIG und GC | 17 (35%) | 15 | 2 | 0 | 0 | 0 | 3 | 4 | 9 | 1 | 0 |
Blood products (RBC, PC, FFP) | 1 (1%) | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Blood products and IVIG/GC | 12 (6%) | 12 | 0 | 0 | 0 | 0 | 1 | 1 | 7 | 3 | 0 |
Total | 217 (100%) | 149 (69%) | 35 (16%) | 20 (9%) | 13 (6%) | 8 (4%) | 52 (24%) | 67 (31%) | 82 (38%) | 8 (4%) | 0 (0%) |
Mean platelet count (/μl) | 6000 | 23500 | 11923 | 10388 | 7390 | 7375 | - |